Search Results
Results found for "Ross Cheloha"
- Dr. Ross Cheloha | Dr. GPCR Ecosystem
Ross Cheloha About this episode Dr. Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Ross and I chatted about his work and transition to an independent investigator; join me to learn more Cheloha’s work. Dr. Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.
- Dr. J. Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
on GPCR signaling in cancer — first as NIH branch chief at NIDCR, then as head of a team that moved cross-country In knockout mice, loss of CXCR3 abolishes response to both anti-PD-1 and anti-CTLA-4, reframing the receptor And the 12 people who moved cross-country from NIH to UCSD did so because of relationships built over NIH: a career that followed the science, not the field 06:19 Operation Exodus — the team that moved cross-country
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
Rosie Dawaliby About Dr. Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially Rosie Dawaliby on the web LinkedIn Dr.
- Dr. Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind — carrying a personal loss in New York and leading a cancer center building that operated at for physical proximity Chance and opportunity as drivers of a scientific career Rotation students as cross-pollinators "These rotation students are like cross-pollination… almost like the sorting hat in Harry Potter."
- YC-Blog (List) | Dr. GPCR Ecosystem
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
gripping conversation, Catherine, a PhD candidate at the University of Michigan, shares how personal loss How loss and lived experience can sharpen scientific focus. But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful
- YC-BioTech | Dr. GPCR Ecosystem
aligned with strategy, not spreadsheets Set up clear deliverables across internal and CRO teams Keep cross-functional Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- Terms and Conditions | Dr. GPCR Ecosystem
Ecosystem.DrGPCR.com shall not be responsible or liable, directly or indirectly, for any damage or loss the third party, and the Customer agrees that Ecosystem.DrGPCR.com shall not be held liable for any loss is not liable, and Customer agrees not to hold Ecosystem.DrGPCR.com responsible, for any damages or losses (including, but not limited to, loss of money, goodwill or reputation, profits, or other intangible attorneys, advertisers, product and service providers, and affiliates harmless from any liability, loss
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
Joshua Gross were enthusiastic about the idea and jumped on board. Dylan Eiger , and Joshua Gross. We are very excited about this event.
- Dr. Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
knockout cell is intrinsically different from the wild-type — complicating any conclusions drawn from loss-of-function Hebert's lab developed caged ligands that cross the plasma membrane and are uncaged intracellularly,
- Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem
models, along with different cell culture systems, to understand the role of immune cell GPCRs and their cross-talk
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
unexpected glucagon-derived peptide behavior How future metabolic therapies may evolve based on receptor cross-talk
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
Core themes: Strategic Planning for Biotech Growth Operational System Design (OS) Cross-functional Team
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
Her current research focuses on how metabolic GPCRs cross-talk and interact to regulate appetite and
- YC-CRO Advisory | Dr. GPCR Ecosystem
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- YC-VC Insights | Dr. GPCR Ecosystem
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
He’s a strong advocate for cross-disciplinary thinking, mentoring young scientists, and building companies
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
You will walk away with a deeper understanding of GPCR internalization, probe specificity, and the cross-disciplinary
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
Duvall emphasizes the value of model systems and cross-species discoveries in GPCR biology.
- Dr. Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
ceiling of single phage libraries Greenfield target selection as a drug discovery strategy Family-level cross-reactivity
- Yamina's Corner | Dr. GPCR Ecosystem
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
- Dr. Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
a disease of signaling imbalance: an overdrive of AT1R activation by angiotensin II, paired with a loss
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
She also mentioned the importance of careful communication, especially when working with a boss who has
- Dr. Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem
Southern blotting, cross-hybridization, and later genetic analyses ultimately showed that some hypothesized
- Dr. Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
Insel believes the training system pushes young researchers to narrow too early, at the cost of the cross-disciplinary
- Dr. Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem
That selective cross-reactivity turned the reagent into a visual probe of which receptor-arrestin pairs
- Dr. Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Have a Fundamental Limitation Traditional β₂-adrenergic agonists can stimulate muscle growth and fat loss
- Content and Conduct Policy | Dr. GPCR Ecosystem
be a delicate balancing act, but if the primary purpose is to attack a protected group, the content crosses
- Content Guidelines | Dr. GPCR Ecosystem
be a delicate balancing act, but if the primary purpose is to attack a protected group, the content crosses






















